CIPLA LTD.

Bleocip

"Bleocip" contains Drug / Molecule called “Bleomycin”. Bleocip is a glycopeptide antibiotic produced by the bacterium Streptomyces verticillus. Bleocip refers to a family of structurally related compounds. The mechanism of action involves breaking DNA.

Details
Specification

Indication

This drug is used for Palliative treatment of Hodgkin disease and non-Hodgkin lymphoma; testicular carcinoma (eg, embryonal cell, choriocarcinoma, teratocarcinoma); sclerosis of malignant pleural effusions; squamous cell carcinomas (e.g., head, neck, penis, cervix, vulva).

Note

Precaution

Bleocip (Bleomycin) is a prescription drug and should be used under proper medical guidance and advice
Contraindicated in pregnancy and lactation.
Hypersensitivity and severe pulmonary disease are also observed.

Updated On Oct 18, 2019 by Admin